Skip to content
Lower risk Medical device recall · FDA · Published October 27, 2022

Cytocell BCL11B Proximal Probe Mislabeling Risk

Cytocell recalls a T-cell malignancy test probe due to incorrect chromomap in package inserts. This may affect lab results but does not pose immediate safety risks.

Take action

Contact the company

Recalling firmCytocell Ltd.418 Cambridge Science Park, Milton Road, Oxford Gene Technology · Cambridge, United Kingdom
✎ GovInfoNow plain-language explainer

Cytocell is recalling a specific lab test probe for T-cell related malignancy because its package insert contains an incorrect chromomap. This could lead to inaccurate lab results but does not pose a direct safety risk to users. Read more at govinfonow.com/recall/59803-cytocell-bcl11b-proximal-probe-mislabeling-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/59803-cytocell-bcl11b-proximal-probe-mislabeling-risk · Updated August 19, 2026 · FDA enforcement record: FDA #Z-0353-2023

Cite this page

“Cytocell BCL11B Proximal Probe Mislabeling Risk.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/59803-cytocell-bcl11b-proximal-probe-mislabeling-risk. Based on FDA recall #Z-0353-2023 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0353-2023%22&limit=1).

Cytocell Ltd. recalled the CytoCell BCL11B Proximal in FITC Spectrum-LDT for investigation of T-cell related malignancy due to a mislabeled package insert, according to the FDA. The Food and Drug Administration announced the Class II recall on Oct. 27, 2022.

How to tell if you have it

  • Brand: Cytocell
  • Product: CytoCell BCL11B Proximal in FITC Spectrum-LDT for investigation T-cell related malignancy
  • Ref: MPD39781
  • Lot: RD22/230/10
  • Distribution: TX

The hazard

The package insert for this analyte specific reagent probe contains an incorrect chromomap that does not match the probe design or specification. The image showing the position the FISH probe maps to on the specific chromosome is erroneous in version 1 of the insert.

Context

GovInfoNow's records show Cytocell Ltd. has 12 other recalls on record since March 15, 2019. Other recent recalls of similar products include HydroMARK Breast Biopsy Marker Recall (April 24, 2026) and Hologic ThinPrep CytoLyt Solution Recall (Dec. 12, 2025).

How to tell if you have this one

Check for the model reference MPD39781 on the package or label. The product was sold with lot number RD22/230/10.

  • Brand
    Cytoc: a company name from the title
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Package Details

    Look for the model reference MPD39781 and lot number RD22/230/10 on the product label.

Where it went and when

Where it was distributed

Distributed in Texas.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: not listedOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: not listedCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: yesTXFlorida: not listedFL

FDA distribution: “TX” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Texas.

Recall timeline

FDA terminated this recall 2.2 years after the firm started it.

1. Firm started the recall: Oct 27, 202212. FDA classified it Class II: Dec 1, 202223. Published in FDA’s Enforcement Report: Dec 7, 202234. FDA terminated the recall: Dec 27, 2024420222024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-0353-2023 (October 27, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0353-2023 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA